CACI International: 29% Rally, No Dividend, and a Debt Problem the Headlines Ignore

The competitor headline says CACI International is up 29.5% after raising 2027 guidance and securing key federal contracts. That part is true. The stock has surged from the low-$430s to above $644 in just five trading days, clearing $265 million in daily turnover as momentum buyers chased a perfect earnings beat.

But here's the thing: CACI doesn't pay a dividend. It carries $7.4 billion in debt on $4.5 billion in equity — a debt-to-equity ratio of nearly 110%. And it trades at 26.6 times trailing earnings, roughly double the multiple of its closest peer in the same business.

That matters because the question isn't whether CACI is a growing business. It is. The question is whether, at this price and this leverage level, the risk/reward still works.

The good news first: pricing power in a mission-critical sector

CACI is classified under Industrials → Professional Services → Research & Consulting, but that classification undersells what it actually does. The company sells information technology and engineering services to the Department of War, the Department of Defense, the CIA, the FBI, the Veterans Administration, and the Office of Personnel Management. They deploy counter-drone systems at the Southern Border, modernize military logistics, and build electronic warfare capabilities for space and intelligence operations.

That is mission-critical work. It is the definition of a TOLL stock — a company that sits on infrastructure the government cannot function without. If CACI goes dark, a defense system fails. That gives them pricing power in a way most software companies don't have. The government is their only customer, but the government is also the one customer that rarely walks away from a contractor it can't replace.

The results back it up. Fiscal 2026 revenue hit $9.6 billion, up 10.9% year-over-year, with 7.2% organic growth. EBITDA margin expanded from 11.2% to 12.3%. Free cash flow jumped 66% to $735 million. The company logged $10.2 billion in contract awards for the year, bringing funded backlog up 28.6% to $5.4 billion.

Then management raised FY2027 guidance to $10.65–$10.85 billion in revenue, adjusted EPS of $32.96–$33.86, and free cash flow of at least $900 million. They beat the Q4 EPS estimate by a wide margin — $8.91 actual versus the $7.21 consensus.

Wall Street responded. UBS raised their price target from $598 to $804. Stifel pushed theirs from $765 to $892. Both kept Buy ratings. The consensus across ten analysts is Buy.

The balance sheet: this is where the story gets harder

Now let's look at what that growth cost. CACI completed the acquisition of ARKA Group in March 2026 for $2.6 billion. ARKA adds space technology, electronic warfare imaging, and Agentic-AI software — a strategically aligned move. But the company funded the deal with new debt: a $500 million tranche of 6.375% fixed-rate senior notes due in 2033, plus an incremental term loan and draws on their revolving credit facility.

The result: total debt of $7.4 billion against total equity of $4.5 billion. Cash on hand is only $192 million. Net debt sits at $4.7 billion. The net debt-to-EBITDA leverage ratio is 5.04 — compared to a market average of roughly 1.38 for companies in this space.

That is not a number I lose sleep over for a low-leverage industrial. For a government services company earning 12.3% EBITDA margins and paying interest on a 6.375% fixed coupon, it means every basis point of margin expansion has to fight through higher interest expense first. Management already acknowledged this — they trimmed their EPS guidance mid-year specifically to account for acquisition-related interest costs.

Return on invested capital has also slipped. ROIC is reported at 7.08%, below CACI's own five-year average of 8.39% and well below the market average of 10.81%. The company is generating cash, yes — but a significant portion now services debt instead of compounding equity value.

No dividend in a dividend growth world

Here's the filter that eliminates CACI for most income-focused portfolios: the company pays zero dividend. None. CACI has publicly told investors not to expect one, and management has chosen to channel cash into acquisitions and share buybacks instead. They authorized a $500 million buyback in 2021, but the ARKA deal effectively redirected that capital strategy toward growth at the expense of current income.

For a retirement-income investor, that is a disqualifier. Not because the business is bad — it isn't. But because the equity yield curve framework I use to evaluate income assets has two dimensions: current yield and dividend growth. CACI has neither. It is a pure capital-appreciation play.

From a compounding math perspective, a stock with no dividend can still create wealth if earnings growth is durable and buybacks are disciplined. CACI's adjusted EPS is projected to grow from $29.83 in FY2026 to roughly $33.40 (midpoint) in FY2027, or about 12% growth. That would be exceptional — if the balance sheet can support it.

Valuation: premium to peers, premium to history

CACI trades at 26.6 times trailing earnings and 28.5 times forward earnings. Its enterprise value to EBITDA is 16.3x. Let's put that in peer context.

Science Applications International (SAIC) — a direct competitor in defense IT services — trades at 13.2x trailing earnings and 11.2x EV/EBITDA, and pays a 1.2% dividend. L3Harris, a broader defense contractor, trades at 28.7x earnings but carries a 1.7% dividend yield and a less levered balance sheet. Boeing, for all its troubles, trades at a much higher multiple because it's an aircraft manufacturer, not a services company.

CACI's 26.6x PE is roughly double SAIC's multiple. The premium demands flawless execution. It demands that margin expansion continues, that the ARKA integration doesn't drag on earnings, and that defense spending keeps rising through FY2028 and beyond.

There is structural support for defense growth — the Professional Services Council's latest federal market forecast projects defense spending to keep climbing through 2035 while civilian agencies face flat or shrinking budgets. CACI sits squarely in the benefiting half of that bifurcation.

But the stock has already rallied 29.5% in five days. The PEG ratio is 3.3, which means even at 12% earnings growth, the stock is paying a steep premium for that growth. You are buying the next several years of margin expansion at today's price.

What would break the thesis

The bull case rests on three assumptions: defense budgets keep growing, CACI's margin expansion continues despite higher interest costs, and the market is willing to maintain a 26x multiple on a highly levered services company. Each one is plausible. None is guaranteed.

Federal budget politics are always a headwind. Even within defense, the shift toward fixed-price contracts (where the contractor bears cost risk) over cost-plus contracts (where the government reimburses costs plus a fee) compresses margins when labor or subcontractor costs rise faster than expected. CACI has a mixed contract portfolio, and margin expansion is partly driven by revenue growth outpacing cost increases — a dynamic that can reverse in a tight labor market.

On the balance sheet side, a 5.04x net debt-to-EBITDA ratio is unsustainable long-term. Management will need to run off that leverage using the $900 million+ of annual free cash flow they now project. At that rate, it would take roughly five years of strong cash flow just to pay down the net debt balance — and that assumes no new acquisitions, no unexpected integration costs, and no economic disruption to contract renewals.

If the ARKA integration underperforms, or if defense procurement slows during a political transition, the leverage becomes a drag rather than an accelerant.

The verdict

CACI International is a high-quality business in a sector with structural tailwinds. The pricing power is real — the government needs what CACI provides, and the backlog and contract awards support multi-year visibility. The FY2026 results and FY2027 guidance are genuinely impressive.

But the 29% rally has pushed the stock into valuation territory that asks for perfection. At 26.6x earnings, 16.3x EV/EBITDA, no dividend, and a 5.04x leverage ratio, you are paying a premium price for a company that still needs to earn back the debt it took on to grow.

This isn't an income play. It isn't a value play. It is a growth story with pricing power, priced as if there is no risk. I believe the business quality deserves a place in a diversified portfolio, but I don't think the current risk/reward supports chasing the momentum at $644. If the stock pulls back to the $500–$550 range — where the forward PE compresses toward 22–24x and the multiple is more in line with what peers command — that would be a different calculation. The compounding math works better when you buy quality at a discount, not at a premium after a five-day sprint.

From an income and risk/reward point of view, this belongs on a watchlist, not in a portfolio at these levels. The business is worthy of attention. The price just hasn't caught up to the patience I require before deploying capital.